Lantheus Medical Imaging has tapped Robert Spurr as vice president of sales and marketing.
Spurr comes to the North Billerica, MA-based firm from Ortho-McNeil, where he served as vice president of sales and marketing, institutional franchise.
Related Reading
Lantheus begins Ablavar marketing, January 20, 2010
Lantheus begins testing new PET agent, September 17, 2009
Lantheus signs Australian moly deal, June 15, 2009
PETNet signs supply deal with Lantheus, June 11, 2009
Lantheus completes Definity study enrollment, May 28, 2009
Copyright © 2010 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
